Novartis bids to buy U.S. vaccine maker Chiron

September 01 2005

Novartis today offered $4.5 billion to purchase the remaining shares of U.S. drugmaker Chiron in a bid to gain a ...

Your Name: *

Your Email Address: *

Recipient(s) Email Address: *

(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)

Subject:*

Your message:

Send Me A Copy

The e-mail address(es) that you supply to use this service will only be used to send the requested article.